We are committed to delivering clinical research to time and target.

Some of our key statistics for 2023-24:

• We recruited 10,672 participants to NIHR portfolio research studies.
• We were the second highest recruiter in England to musculoskeletal studies with 1,243 participants.
• We recruited the first ever UK participants to 11 research studies.  Our gastroenterology team alone had 4 first recruits and dermatology 3.
• We opened 19 NCA sponsored research studies, 10 were NIHR portfolio research studies.
• We were in the top 10% for recruitment in 11 speciality areas – critical care, dementias and neurodegeneration, dermatology, gastroenterology, health services research, musculoskeletal disorders, oral and dental health, primary care, renal disorders, respiratory disorders, and stroke.
• We were in the top 5% for recruitment in critical care, dermatology, musculoskeletal disorders, renal disorders, and stroke.
• 99.2% of research participants who gave feedback said they felt valued at Northern Care Alliance NHS Foundation Trust.
• 14 early phase studies were set-up bringing novel cutting edge technology to patients.
• NCA has 61 Investigators supporting industry research and 18 of those are Chief Investigators.
• In May 2023 NCA R&I approved our first gene therapy study and successfully recruited our first participant in July 2023.

If you have any queries or comments about the information provided or our performance, please contact Katie Doyle.